FOLFIRI-bevacizumab regimen

{
  "id": "MLC-T-ONC-003289",
  "term": "FOLFIRI-bevacizumab regimen",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A chemotherapy combination used as an initial treatment of colorectal cancer that has spread. It includes the drugs leucovorin (folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab. Also called FOLFIRI-Avastin regimen and FOLFIRI-bevacizumab.",
    "A regimen consisting of bevacizumab, fluorouracil, irinotecan and leucovorin that may be used in the treatment of appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma."
  ],
  "synonyms": [
    "FOLFIRI-Avastin regimen",
    "FOLFIRI-bevacizumab",
    "folinic acid-fluorouracil-irinotecan-bevacizumab regimen",
    "FOLFIRI/bevacizumab regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/folfiri-bevacizumab-regimen/"
}